This program project is an interdisciplinary effort to broaden our understanding of the roles that eicosanoids and hemostatic factors play in the pathogenesis of cerebrovascular thrombosis and to enhance our knowledge concerning the use of pharmacological agents and gene transfer for prevention of arterial diseases and stroke. Our major goal is to bring the basic investigations into clinical applications in improved care of patients with stroke and allied disorders. Substantial progresses have been made during the previous period. These progresses have led to the proposal of new specific aims. This renewal application consists of four interrelated projects and one core unit. Wu's project aims at understanding the regulation at molecular level of key enzymes that catalyze the biosynthesis of thromboxane A and prostacyclin. It focuses on elucidating the mechanism by which cytokines and growth factors induce prostaglandin H synthases and salicylates suppress their expression. Kulmacz's project aims at mapping the topology of thromboxane synthase and determining the structure-function relation of this enzyme. McIntyre and Hellum project study the expression of hemostatic factors under shear stress. Core B laboratory procedure development and standardization as well as reagent preparation. Thus, the scope of the program ranges from molecular and cell biology to clinical patient investigations, and there exists an exciting potential for a rapid application of basic information to clinical management of stroke and vice versa. The program involves professional personnel with a long record of interests in stroke research who have different but complementary backgrounds and expertise in hematology, hemostasis and thrombosis, neurobiology, cell and molecular biology, neurology, biochemistry, pharmacology, tissue culture, enzymology and analytical chemistry. It is intended that this program will enable several laboratories to work individually and together to achieve the highest degree of innovation and productivity.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
5P50NS023327-12
Application #
2332940
Study Section
Neurological Disorders Program Project Review A Committee (NSPA)
Program Officer
Jacobs, Tom P
Project Start
1985-08-01
Project End
1999-01-31
Budget Start
1997-05-01
Budget End
1998-01-31
Support Year
12
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Texas Health Science Center Houston
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Houston
State
TX
Country
United States
Zip Code
77225
Chen, Pei-Feng; Wu, Kenneth K (2009) Two synthetic peptides corresponding to the proximal heme-binding domain and CD1 domain of human endothelial nitric-oxide synthase inhibit the oxygenase activity by interacting with CaM. Arch Biochem Biophys 486:132-40
Wu, Jui-Sheng; Cheung, Wai-Mui; Tsai, Yau-Sheng et al. (2009) Ligand-activated peroxisome proliferator-activated receptor-gamma protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3 epsilon upregulation. Circulation 119:1124-34
Liou, Jun-Yang; Ellent, David P; Lee, Sang et al. (2007) Cyclooxygenase-2-derived prostaglandin e2 protects mouse embryonic stem cells from apoptosis. Stem Cells 25:1096-103
Liou, Jun-Yang; Lee, Sang; Ghelani, Dipak et al. (2006) Protection of endothelial survival by peroxisome proliferator-activated receptor-delta mediated 14-3-3 upregulation. Arterioscler Thromb Vasc Biol 26:1481-7
Cieslik, Katarzyna A; Deng, Wu-Guo; Wu, Kenneth K (2006) Essential role of C-Rel in nitric-oxide synthase-2 transcriptional activation: time-dependent control by salicylate. Mol Pharmacol 70:2004-14
Deng, Wu-Guo; Tang, Shao-Tzu; Tseng, Hui-Ping et al. (2006) Melatonin suppresses macrophage cyclooxygenase-2 and inducible nitric oxide synthase expression by inhibiting p52 acetylation and binding. Blood 108:518-24
Wu, Kenneth K (2006) Analysis of protein-DNA binding by streptavidin-agarose pulldown. Methods Mol Biol 338:281-90
Lin, Teng-Nan; Cheung, Wai-Mui; Wu, Jui-Sheng et al. (2006) 15d-prostaglandin J2 protects brain from ischemia-reperfusion injury. Arterioscler Thromb Vasc Biol 26:481-7
Wu, Kenneth K (2006) Transcription-based COX-2 inhibition: a therapeutic strategy. Thromb Haemost 96:417-22
Liou, Jun-Yang; Aleksic, Nena; Chen, Shu-Fen et al. (2005) Mitochondrial localization of cyclooxygenase-2 and calcium-independent phospholipase A2 in human cancer cells: implication in apoptosis resistance. Exp Cell Res 306:75-84

Showing the most recent 10 out of 63 publications